| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |